Galecto Inc
$28.69
21
-$0.22-0.76% Monday 20:00
Statistics
Day High
30.09
Day Low
26.43
52W High
38.33
52W Low
2.01
Volume
231,441
Avg. Volume
161,023
Mkt Cap
38.07M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
24AprExpected
Expected EPS
-0.300355
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-42.88MNet Income
Analyst Ratings
$44.25Average Price Target
The highest estimate is 46.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow GLTO. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Madrigal Pharmaceuticals
MDGL
Mkt Cap9.34B
Galapagos NV
GLPG
Mkt Cap2.09B
ProQR Therapeutics N.V
PRQR
Mkt Cap289.7M
Gilead Sciences
GILD
Mkt Cap148.78B
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Pfizer
PFE
Mkt Cap140.15B
Abbvie
ABBV
Mkt Cap385.18B
Novartis
NVS
Mkt Cap237.61B
About
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts.
Show more...
CEO
Dr. Hans T. Schambye M.D., Ph.D.
Employees
5
Country
US
ISIN
US36322Q1076
Listings
0 Comments
Share your thoughts
FAQ
What is Galecto Inc stock price today?▼
The current price of GLTO is $28.69 USD — it has decreased by -0.76% in the past 24 hours. Watch Galecto Inc stock price performance more closely on the chart.
What is Galecto Inc stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Galecto Inc stocks are traded under the ticker GLTO.
Is Galecto Inc stock price growing?▼
GLTO stock has risen by +0% compared to the previous week, the month change is a -3.01% fall, over the last year Galecto Inc has showed a +917.38% increase.
What is Galecto Inc market cap?▼
Today Galecto Inc has the market capitalization of 38.07M
When is the next Galecto Inc earnings date?▼
Galecto Inc is going to release the next earnings report on April 24, 2026.
What were Galecto Inc earnings last quarter?▼
GLTO earnings for the last quarter are -2.36 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Galecto Inc revenue for the last year?▼
Galecto Inc revenue for the last year amounts to 0 USD.
What is Galecto Inc net income for the last year?▼
GLTO net income for the last year is -42.88M USD.
How many employees does Galecto Inc have?▼
As of April 01, 2026, the company has 5 employees.
In which sector is Galecto Inc located?▼
Galecto Inc operates in the Health Care sector.
When did Galecto Inc complete a stock split?▼
The last stock split for Galecto Inc was on August 30, 2024 with a ratio of 1:25.
Where is Galecto Inc headquartered?▼
Galecto Inc is headquartered in Copenhagen, US.